Skip to main content
SpringerLink
Log in

Stimulation ovarienne, déclenchement de l’ovulation et soutien de la phase lutéale

  • Chapter
Physiologie, pathologie et thérapie de la reproduction chez l’humain

  • 906 Accesses

Résumé

L’utilisation de la stimulation ovarienne a pour objectif d’augmenter les taux de succès de la fécondation in vitro en permettant le développement de nombreux follicules, favorisant ainsi l’obtention d’un nombre conséquent d’ovocytes et d’embryons. Elle est également utilisée seule ou en association avec des inséminations intra-utérines. Dans ce cas, le but est d’induire une ovulation. Dans le cadre des inséminations ou des stimulations simples, c’est-à-dire sans insémination, la stimulation se veut douce pour faire émerger entre un à trois follicules au plus et ainsi éviter au mieux les grossesses multiples.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Eibschitz I, Belaisch-Allart J, Frydman R (1986) In vitro fertilization management and results in stimulated cycles with spontaneous LH discharge. Fertil Steril 45:231–234

    PubMed  CAS  Google Scholar 

  2. Rizk B, Smitz J (1992) Ovarian hyperstimulation syndrome after superovulation using LH-RH agonists for IVF and related procedures. Hum Reprod 7:320–327

    PubMed  CAS  Google Scholar 

  3. Albano C, Smitz J, Camus M et al. (1997) Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 67:917–922

    Article  PubMed  CAS  Google Scholar 

  4. Olivennes F, Fanchin R, Bouchard P et al. (1995) Schedulded administration of GNRH antagonist (Cetrorelix) on day 8 of in vitro fertilization cycles: a pilot study. Hum Reprod 10:1382–1386

    PubMed  CAS  Google Scholar 

  5. Kousta E, White Dm, Franks S (1997) Modern use of clomiphene citrate in induction of ovulation. Human Reprod Update 4:358–365

    Google Scholar 

  6. Coomarasamy A, Afnan M, Cheema D et al. (2008) Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment:a systematic review and meta-analysis. Human Reproduction 23:310–315

    Article  PubMed  CAS  Google Scholar 

  7. Bosch E, Vidal C, Labarta E, Simon C, Remohi J, Pellicer A (2008) Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists-a randomized study. Human Reproduction 23:2346–2351

    Article  PubMed  CAS  Google Scholar 

  8. Rongières C (2006) Monitoring ovarian stimulation: are hormonal assessments necessary? J Gynecol Obstet Biol Reprod 35:2S39–2S41

    Google Scholar 

  9. Kwan I, Bhattacharya S, Mcneil A, Van Rumste MME (2008) Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI) (Review) Cochrane Data Base 2:CD005289

    Google Scholar 

  10. Hugues JN, Barlow DH, Rosenwaks Z et al. (2003) Improvment in consistency of response to ovarian stimulation with recombinent human follicule hormone resulting from a new method for calibrating the therapeutic preparation. Reprod Biomed Online 6:185–190

    Article  PubMed  CAS  Google Scholar 

  11. Kosmas P, Tatsioni A, Kolibianakis EM et al. (2008) Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. Fertil Steril 90:367–372

    Article  PubMed  Google Scholar 

  12. Isikoglu M, Ozdem S, Berkkanoglu M, Jammal H, Senturk Z, Ozgur K (2007) Single-dose depot leuprolide is as efficient as daily short acting leuprolide in ICSI cycles. Hum Reprod 22:1657–1661

    Article  PubMed  CAS  Google Scholar 

  13. Hugues JN (2002) Contribution of exogenous LH during ovarian stimulation: for a targeted indication Gynecol Obstet Fertil 30:79–83.

    Article  PubMed  CAS  Google Scholar 

  14. Surrey ES, Schoolcraft WB (2000) Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 73:667–676

    Article  PubMed  CAS  Google Scholar 

  15. Ludwig M, Katalinic A, Banz C, Schröder Ak, Löning M, Weiss JM (2002) Tailoring the GnRH antagonist cetrorelix acetate to individual patients’ needs in ovarian stimulation for IVF: results of a prospective, randomized study. Hum Reprod 17:2842–2845

    Article  PubMed  CAS  Google Scholar 

  16. Ludwig M, Katalinic A, Diedrich K (2001) Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to thelong protocol Meta-analysis. Arch Gynecol Obstet 265:175–182

    Article  PubMed  CAS  Google Scholar 

  17. Rongières-Bertrand C, Olivennes F, Righini C et al. (1999) Revival of the natural cycles in in vitro fertilization with the use of a new GnRH antagonist (Cetrorelix): a pilot study with minimal stimulation. Human Reprod 14:683–688

    Article  Google Scholar 

  18. Kolibianakis em (2005) GnRH antagonists in IVF. RBM Online 10:705–712

    PubMed  Google Scholar 

  19. Abdalla HI, Ah-Moye M, Brinsden P, Howe Dl, Okonofua F, Craft I (1987) The effect of the dose of hCG and the type of gonadotropin stimulation on ovocyte recovery rate in an in vitro fertilization program. Fertil Steril 48:958–963

    PubMed  CAS  Google Scholar 

  20. Emperaire JC, Parneix I, Broussin B, Ruffie A (1998) Triggering ovulation with different doses of human chorionic gonadotropin (hCG) in stimulated cycles. Fertil Steril 70(Suppl. 1)

    Google Scholar 

  21. De Ziegler D, Bulletti C, De Monstier B, Jääskeläinen AS (1997) The first uterine pass effect. Ann NY Acad Sci 828:291–299

    Article  PubMed  Google Scholar 

  22. Aboulghar M (2009) Luteal support in reproduction: when, what and how? Curr Opin Obstet Gynecol 21:279–284

    Article  PubMed  Google Scholar 

  23. Kolibianakis EM, Venetis CA, Papanikolaou EG, Diedrich K, Tarlatzis BC, Griesinger G (2008) Estrogen addition to progesterone for luteal phase support in cycles stimulated with GnRH analogues and gonadotrophins for IVF: a systematic review and meta-analysis. Hum Reprod 23:1346–1354

    Article  PubMed  CAS  Google Scholar 

  24. Poustie J, Dodd S, Drakeley AJ (2007) Low-dose aspirin for in vitro fertilisation. Cochrane Database Syst Rev 17:CD004832

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre d’AMP SIHCUS CMCO, 19, rue Louis-Pasteur, 67300, Schiltigheim

    C. Rongières & L. Moreau

  2. Clinique du Diaconnat, 14, boulevard Roosevelt BP 2399, 68067, Mulhouse Cedex

    E. Lamarca & P. Weber

Authors
  1. C. Rongières
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Moreau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Lamarca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Rongières, C., Moreau, L., Lamarca, E., Weber, P. (2011). Stimulation ovarienne, déclenchement de l’ovulation et soutien de la phase lutéale. In: Physiologie, pathologie et thérapie de la reproduction chez l’humain. Springer, Paris. https://doi.org/10.1007/978-2-8178-0061-5_36

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0061-5_36

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0060-8

  • Online ISBN: 978-2-8178-0061-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation